Dopamine D4 receptor deficiency in mice alters behavioral responses to anxiogenic stimuli and the psychostimulant methylphenidate

Thomas M. Keck, Katherine L. Suchland, Charles C. Jimenez, David Grandy

    Research output: Contribution to journalArticle

    16 Citations (Scopus)

    Abstract

    An allele of the human dopamine D4 receptor (D4R) gene (DRD4), containing seven tandem repeats of a 48-base nucleotide sequence (DRD4.7), has been reproducibly found in novelty seekers, substance abusers, and individuals with attention-deficit hyperactivity disorder. One hypothesis predicts the resultant protein product of the DRD4.7 polymorphism is deficient in G protein-coupled signaling. If attenuated D4R signaling contributes to these complex behaviors, then wild-type (WT) mice and mice completely lacking D4Rs (D4R KO) might be expected to display significantly different behavioral responses to stimuli known to affect dopamine signaling, such as novelty or psychostimulants. Adolescent male D4R KO mice exhibited greater locomotor activity and spent less time in the anxiogenic center of a novel open field environment than WT littermates. The presence of D4Rs had no effect on emergence into a novel environment from a sheltered space or exploration of a novel object. Low doses of acute methylphenidate (MP) had no effect on the exploration of a novel object, but dose-dependently increased the latency to emerge into a novel environment from a sheltered space. WT and D4R KO mice responded differently to high doses of acute MP, displaying significantly elevated locomotor activity and reduced stereotypy relative to WT mice. Chronic MP treatment produced enhanced locomotor sensitization in D4R KO mice, however this effect could not be fully recapitulated using the putative D4R antagonist L-745-870. These studies suggest that the roles of D4R signaling in novelty-seeking behaviors and the response to psychostimulants are not as clear as previously reported, and that some of these effects may be due to developmental compensatory effects as a consequence of lost D4R expression. If the DRD4.7 variant results in deficient D4R signaling in vivo, this may contribute to an elevated risk of sensitization to drugs of abuse including psychostimulants used to treat ADHD.

    Original languageEnglish (US)
    Pages (from-to)831-841
    Number of pages11
    JournalPharmacology Biochemistry and Behavior
    Volume103
    Issue number4
    DOIs
    StatePublished - Feb 2013

    Fingerprint

    Dopamine D4 Receptors
    Methylphenidate
    Locomotion
    Tandem Repeat Sequences
    Street Drugs
    Space Flight
    Exploratory Behavior
    Polymorphism
    GTP-Binding Proteins
    Attention Deficit Disorder with Hyperactivity
    Dopamine
    Nucleotides
    Genes
    Alleles
    Proteins

    Keywords

    • Anxiety
    • Attention deficit hyperactivity disorder
    • Methylphenidate
    • Novelty
    • Stereotypy

    ASJC Scopus subject areas

    • Biochemistry
    • Clinical Biochemistry
    • Pharmacology
    • Toxicology
    • Behavioral Neuroscience
    • Biological Psychiatry

    Cite this

    Dopamine D4 receptor deficiency in mice alters behavioral responses to anxiogenic stimuli and the psychostimulant methylphenidate. / Keck, Thomas M.; Suchland, Katherine L.; Jimenez, Charles C.; Grandy, David.

    In: Pharmacology Biochemistry and Behavior, Vol. 103, No. 4, 02.2013, p. 831-841.

    Research output: Contribution to journalArticle

    Keck, Thomas M. ; Suchland, Katherine L. ; Jimenez, Charles C. ; Grandy, David. / Dopamine D4 receptor deficiency in mice alters behavioral responses to anxiogenic stimuli and the psychostimulant methylphenidate. In: Pharmacology Biochemistry and Behavior. 2013 ; Vol. 103, No. 4. pp. 831-841.
    @article{ad08f905969d4248bb79234ca3b770d3,
    title = "Dopamine D4 receptor deficiency in mice alters behavioral responses to anxiogenic stimuli and the psychostimulant methylphenidate",
    abstract = "An allele of the human dopamine D4 receptor (D4R) gene (DRD4), containing seven tandem repeats of a 48-base nucleotide sequence (DRD4.7), has been reproducibly found in novelty seekers, substance abusers, and individuals with attention-deficit hyperactivity disorder. One hypothesis predicts the resultant protein product of the DRD4.7 polymorphism is deficient in G protein-coupled signaling. If attenuated D4R signaling contributes to these complex behaviors, then wild-type (WT) mice and mice completely lacking D4Rs (D4R KO) might be expected to display significantly different behavioral responses to stimuli known to affect dopamine signaling, such as novelty or psychostimulants. Adolescent male D4R KO mice exhibited greater locomotor activity and spent less time in the anxiogenic center of a novel open field environment than WT littermates. The presence of D4Rs had no effect on emergence into a novel environment from a sheltered space or exploration of a novel object. Low doses of acute methylphenidate (MP) had no effect on the exploration of a novel object, but dose-dependently increased the latency to emerge into a novel environment from a sheltered space. WT and D4R KO mice responded differently to high doses of acute MP, displaying significantly elevated locomotor activity and reduced stereotypy relative to WT mice. Chronic MP treatment produced enhanced locomotor sensitization in D4R KO mice, however this effect could not be fully recapitulated using the putative D4R antagonist L-745-870. These studies suggest that the roles of D4R signaling in novelty-seeking behaviors and the response to psychostimulants are not as clear as previously reported, and that some of these effects may be due to developmental compensatory effects as a consequence of lost D4R expression. If the DRD4.7 variant results in deficient D4R signaling in vivo, this may contribute to an elevated risk of sensitization to drugs of abuse including psychostimulants used to treat ADHD.",
    keywords = "Anxiety, Attention deficit hyperactivity disorder, Methylphenidate, Novelty, Stereotypy",
    author = "Keck, {Thomas M.} and Suchland, {Katherine L.} and Jimenez, {Charles C.} and David Grandy",
    year = "2013",
    month = "2",
    doi = "10.1016/j.pbb.2012.12.006",
    language = "English (US)",
    volume = "103",
    pages = "831--841",
    journal = "Pharmacology Biochemistry and Behavior",
    issn = "0091-3057",
    publisher = "Elsevier Inc.",
    number = "4",

    }

    TY - JOUR

    T1 - Dopamine D4 receptor deficiency in mice alters behavioral responses to anxiogenic stimuli and the psychostimulant methylphenidate

    AU - Keck, Thomas M.

    AU - Suchland, Katherine L.

    AU - Jimenez, Charles C.

    AU - Grandy, David

    PY - 2013/2

    Y1 - 2013/2

    N2 - An allele of the human dopamine D4 receptor (D4R) gene (DRD4), containing seven tandem repeats of a 48-base nucleotide sequence (DRD4.7), has been reproducibly found in novelty seekers, substance abusers, and individuals with attention-deficit hyperactivity disorder. One hypothesis predicts the resultant protein product of the DRD4.7 polymorphism is deficient in G protein-coupled signaling. If attenuated D4R signaling contributes to these complex behaviors, then wild-type (WT) mice and mice completely lacking D4Rs (D4R KO) might be expected to display significantly different behavioral responses to stimuli known to affect dopamine signaling, such as novelty or psychostimulants. Adolescent male D4R KO mice exhibited greater locomotor activity and spent less time in the anxiogenic center of a novel open field environment than WT littermates. The presence of D4Rs had no effect on emergence into a novel environment from a sheltered space or exploration of a novel object. Low doses of acute methylphenidate (MP) had no effect on the exploration of a novel object, but dose-dependently increased the latency to emerge into a novel environment from a sheltered space. WT and D4R KO mice responded differently to high doses of acute MP, displaying significantly elevated locomotor activity and reduced stereotypy relative to WT mice. Chronic MP treatment produced enhanced locomotor sensitization in D4R KO mice, however this effect could not be fully recapitulated using the putative D4R antagonist L-745-870. These studies suggest that the roles of D4R signaling in novelty-seeking behaviors and the response to psychostimulants are not as clear as previously reported, and that some of these effects may be due to developmental compensatory effects as a consequence of lost D4R expression. If the DRD4.7 variant results in deficient D4R signaling in vivo, this may contribute to an elevated risk of sensitization to drugs of abuse including psychostimulants used to treat ADHD.

    AB - An allele of the human dopamine D4 receptor (D4R) gene (DRD4), containing seven tandem repeats of a 48-base nucleotide sequence (DRD4.7), has been reproducibly found in novelty seekers, substance abusers, and individuals with attention-deficit hyperactivity disorder. One hypothesis predicts the resultant protein product of the DRD4.7 polymorphism is deficient in G protein-coupled signaling. If attenuated D4R signaling contributes to these complex behaviors, then wild-type (WT) mice and mice completely lacking D4Rs (D4R KO) might be expected to display significantly different behavioral responses to stimuli known to affect dopamine signaling, such as novelty or psychostimulants. Adolescent male D4R KO mice exhibited greater locomotor activity and spent less time in the anxiogenic center of a novel open field environment than WT littermates. The presence of D4Rs had no effect on emergence into a novel environment from a sheltered space or exploration of a novel object. Low doses of acute methylphenidate (MP) had no effect on the exploration of a novel object, but dose-dependently increased the latency to emerge into a novel environment from a sheltered space. WT and D4R KO mice responded differently to high doses of acute MP, displaying significantly elevated locomotor activity and reduced stereotypy relative to WT mice. Chronic MP treatment produced enhanced locomotor sensitization in D4R KO mice, however this effect could not be fully recapitulated using the putative D4R antagonist L-745-870. These studies suggest that the roles of D4R signaling in novelty-seeking behaviors and the response to psychostimulants are not as clear as previously reported, and that some of these effects may be due to developmental compensatory effects as a consequence of lost D4R expression. If the DRD4.7 variant results in deficient D4R signaling in vivo, this may contribute to an elevated risk of sensitization to drugs of abuse including psychostimulants used to treat ADHD.

    KW - Anxiety

    KW - Attention deficit hyperactivity disorder

    KW - Methylphenidate

    KW - Novelty

    KW - Stereotypy

    UR - http://www.scopus.com/inward/record.url?scp=84873326261&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84873326261&partnerID=8YFLogxK

    U2 - 10.1016/j.pbb.2012.12.006

    DO - 10.1016/j.pbb.2012.12.006

    M3 - Article

    C2 - 23262298

    AN - SCOPUS:84873326261

    VL - 103

    SP - 831

    EP - 841

    JO - Pharmacology Biochemistry and Behavior

    JF - Pharmacology Biochemistry and Behavior

    SN - 0091-3057

    IS - 4

    ER -